Hurlburt Elizabeth
SEC CIK 1735256 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRMD | CorMedix Inc. | EVP, Head of Clinical Ops | 270.5K | — | $2.28M | 17 | 2024-01-12 | 2026-08-29 |
Most active insiders at CRMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dillione Janet | Dir | — | $1.55M |
| 2 | Lefkowitz Steven W | Dir | — | $475.2K |
| 3 | Todisco Joseph | CEO, Dir | — | $360.0K |
| 4 | Kaplan Myron | Dir | $275.5K | — |
| 5 | DUNTON ALAN W | Dir | — | $260.0K |
| 6 | Seckler Michael David | Chief Commercial Off | — | — |
| 7 | Zelnick Kaufman Beth | CLO | — | — |
| 8 | Duncan Gregory Scott | Dir | — | — |
| 9 | Blum Susan | CFO | — | — |
| 10 | Hurlburt Elizabeth | COO | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 20:18 | 2026-08-29 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | F - Tax | $8.30 | -8,076 | 270.5K | -3% | -$67.0K | |
| 2026-02-06 | 2026-02-04 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +36.0K | 278.5K | +15% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | F - Tax | $7.27 | -10.8K | 242.5K | -4% | -$78.4K | |
| 2026-01-27 | 2026-01-23 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +93.0K | 253.3K | +58% | $0 | |
| 2026-01-20 | 2026-01-12 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | F - Tax | $7.15 | -5,794 | 160.3K | -3% | -$41.4K | |
| 2026-01-06 | 2026-01-02 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | F - Tax | $12.16 | -10.9K | 166.1K | -6% | -$132.5K | |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | M - OptEx | $1.45 | +54.0K | 189.9K | +40% | +$78.3K |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | S - Sale+OE | $13.18 | -54.0K | 177.0K | -23% | -$711.8K |
| A | 2025-09-08 | 2025-08-29 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | F - Tax | $14.83 | -8,424 | 177.0K | -5% | -$124.9K |
| 2025-09-03 | 2025-08-29 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +69.7K | 185.4K | +60% | $0 | |
| 2025-01-14 | 2025-01-10 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | EVP | F - Tax | $11.19 | -5,790 | 115.7K | -5% | -$64.8K | |
| 2025-01-06 | 2025-01-02 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | EVP | F - Tax | $8.22 | -11.4K | 121.5K | -9% | -$93.5K | |
| 2025-01-06 | 2025-01-02 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | EVP | A - Grant | $0.00 | +87.5K | 132.9K | +193% | $0 | |
| D | 2024-11-18 | 2024-11-14 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | EVP | S - Sale+OE | $11.18 | -140.0K | 45.4K | -76% | -$1.57M |
| DM | 2024-11-18 | 2024-11-14 | CRMD | CorMedix Inc. | Hurlburt Elizabeth | EVP | M - OptEx | $4.48 | +140.0K | 45.4K | New | +$627.7K |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | F - Tax | $3.47 | -4,603 | 53.4K | -8% | -$16.0K |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | A - Grant | $0.00 | +50.0K | 58.0K | +625% | $0 |
Purchase Sale Sale after option exercise All abbreviations